Paige Obtains NHSx Award Allowing It To Launch AI Prostate Test
NHSx has awarded Paige an undisclosed sum of money to support development of its AI-powered prostate cancer detection tool in clinical settings in the UK.
You may also be interested in...
Paige’s AI has obtained CE-IVD and UKCA marks, allowing the launch of a breakthrough product that can spot biomarkers from images.
The company expects the major commercial collaboration and geographical roll-out will lead to increased adoption of Agendia’s breast cancer diagnostics.
The Paige Prostate is a first-of-its-kind digital prostate imaging analysis software that can act as an extra pair of eyes to help pathologists spot cancer cells.